Kan Yang
Impact in
-
- Cholinesterase and Neurodegenerative Diseases
-
- Synthesis and biological activity
- Click Chemistry and Applications
- Synthesis and Biological Evaluation
Papers in
-
- Sphingolipid Metabolism and Signaling 7
- Cancer therapeutics and mechanisms 4
-
- Synthesis and biological activity 7
- Co-authors
- Yali Song (12 shared papers)Jinxin Wang (9 shared papers)Martin Lipkin (2 shared papers)Xiaoqiang Qiao (7 shared papers)Zhenming Liu (6 shared papers)Fei Cao (7 shared papers)Youzhi Wang (4 shared papers)Siran Feng (2 shared papers)
- Journals
- European Journal of Medicinal Chemistry (5 papers)Journal of Medicinal Chemistry (4 papers)Future Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry (3 papers)Medicinal Chemistry Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Kan Yang
31 papers receiving 323 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 74
- Organic Chemistry 115
- Toxicology 13
- Process Chemistry and Technology 11
- Biological Psychiatry 7
Countries citing papers authored by Kan Yang
This map shows the geographic impact of Kan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kan Yang more than expected).
Fields of papers citing papers by Kan Yang
This network shows the impact of papers produced by Kan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kan Yang. The network helps show where Kan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 37 | |
| 2 | 2001 | 32 | |
| 3 | 2022 | 26 | |
| 4 | 2020 | 24 | |
| 5 | 2020 | 20 | |
| 6 | 2023 | 18 | |
| 7 | 1990 | 16 | |
| 8 | 2022 | 16 | |
| 9 | 2019 | 14 | |
| 10 | 2024 | 14 | |
| 11 | 2022 | 12 | |
| 12 | 2020 | 12 | |
| 13 | 2022 | 10 | |
| 14 | 2023 | 9 | |
| 15 | 2022 | 8 | |
| 16 | 2019 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2023 | 5 |
About Kan Yang
Kan Yang is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Oncology and Cancer Research, having authored 34 papers that have together received 327 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (7 papers), Synthesis and biological activity (7 papers), Cancer therapeutics and mechanisms (4 papers), Peptidase Inhibition and Analysis (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Cancer, Lipids, and Metabolism (3 papers), Computational Drug Discovery Methods (3 papers) and Calcium signaling and nucleotide metabolism (2 papers). The work is most often cited by research in Pharmacology (74 citations), Organic Chemistry (115 citations), Toxicology (13 citations), Process Chemistry and Technology (11 citations) and Biological Psychiatry (7 citations). Kan Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yali Song, Jinxin Wang, Martin Lipkin, Xiaoqiang Qiao, Zhenming Liu, Fei Cao, Youzhi Wang, Siran Feng, Jiajia Feng and Longfei Li. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Future Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Medicinal Chemistry Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.